Opportunity ID: 358729

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525BCRPBTA12
Funding Opportunity Title: DoD Breast Cancer Breakthrough Award Levels 1 and 2
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 20
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Apr 22, 2025
Last Updated Date: May 23, 2025
Original Closing Date for Applications: Jun 27, 2025
Current Closing Date for Applications: Jun 27, 2025
Archive Date: Jul 27, 2025
Estimated Total Program Funding: $33,700,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided. Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact. The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level has a defined research scope. The current program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

·        This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science and Prevention Studies option. With compelling justification, population science and prevention studies may request higher levels of funding and an additional year in the period of performance.

·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn. 

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
Multiple changes have been made throughout the Program Announcement (PA). The main changes are reflected on Pages 4, 9 and 10 of the PA to reflect a change in the funding details from a direct cost cap to a total cost cap. Additionally, the Estimated Total Program Funding amount has been updated in the PA and synopsis. May 23, 2025
Multiple changes have been made throughout the Program Announcement (PA). The main changes are reflected on Pages 4 and 10 of the PA to reflect a change in the funding details from a direct cost cap to a total cost cap. Additionally, the Estimated Total Program Funding amount has been updated in the PA and synopsis. Apr 22, 2025
Apr 22, 2025

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525BCRPBTA12
Funding Opportunity Title: DoD Breast Cancer Breakthrough Award Levels 1 and 2
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 20
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: Apr 22, 2025
Last Updated Date: May 23, 2025
Original Closing Date for Applications: Jun 27, 2025
Current Closing Date for Applications: Jun 27, 2025
Archive Date: Jul 27, 2025
Estimated Total Program Funding: $33,700,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided. Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact. The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level has a defined research scope. The current program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

·        This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science and Prevention Studies option. With compelling justification, population science and prevention studies may request higher levels of funding and an additional year in the period of performance.

·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn. 

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525BCRPBTA12
Funding Opportunity Title: DoD Breast Cancer Breakthrough Award Levels 1 and 2
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 20
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Apr 22, 2025
Last Updated Date: May 23, 2025
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 27, 2025
Archive Date: Jul 27, 2025
Estimated Total Program Funding: $33,700,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided. Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact. The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level has a defined research scope. The current program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

·        This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science and Prevention Studies option. With compelling justification, population science and prevention studies may request higher levels of funding and an additional year in the period of performance.

·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn. 

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525BCRPBTA12
Funding Opportunity Title: DoD Breast Cancer Breakthrough Award Levels 1 and 2
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 20
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 22, 2025
Last Updated Date: Apr 22, 2025
Original Closing Date for Applications:
Current Closing Date for Applications: Jun 27, 2025
Archive Date: Jul 27, 2025
Estimated Total Program Funding: $37,700,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) overarching challenges, unless adequate justification for exception is provided. Applications must address the challenge in a way that can lead to or make a breakthrough and have major impact. The FY25 Breakthrough Award mechanism contains three different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level has a defined research scope. The current program announcement discusses the Breakthrough Award Levels 1 and 2.

Distinctive Features:

·        This funding mechanism allows for applications submitted under Funding Level 1 or Funding Level 2. Funding Level 2 also includes a Population Science and Prevention Studies option. With compelling justification, population science and prevention studies may request higher levels of funding and an additional year in the period of performance.

·        This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, applications may be withdrawn if both the initiating and partnering applications are not submitted by the full application deadline or if the initiating or partnering application is administratively withdrawn. 

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 358729 Full Announcement-FY25 BCRP BTA12 -> HT942525BCRPBTA12_GG2.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00290613 Apr 22, 2025 Jun 27, 2025 View

Package 1

Mandatory forms

358729 RR_SF424_5_0-5.0.pdf

358729 AttachmentForm_1_2-1.2.pdf

358729 RR_PersonalData_1_2-1.2.pdf

358729 RR_KeyPersonExpanded_4_0-4.0.pdf

358729 RR_Budget_3_0-3.0.pdf

358729 PerformanceSite_4_0-4.0.pdf

Optional forms

358729 RR_SubawardBudget30_3_0-3.0.pdf

2025-07-13T19:22:35-05:00

Share This Post, Choose Your Platform!

About the Author: